captopril has been researched along with Carcinoma, Ductal, Breast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Kim, YT; Molteni, A; Small, W; Taylor, JM; Ward, WF | 1 |
| Kim, YT; Molteni, A; Small, W; Taylor, JM; Ts'ao, CH; Ward, WF | 1 |
2 other study(ies) available for captopril and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Breast Neoplasms; Captopril; Carcinoma, Ductal, Breast; Cell Division; Female; Humans; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1997 |
Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Captopril; Carcinoma, Ductal, Breast; Copper; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydrogen Peroxide; Lisinopril; Penicillamine; Tumor Cells, Cultured | 1999 |